HYDROCODONE BITARTRATE AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Bitartrate And Acetaminophen, and when can generic versions of Hydrocodone Bitartrate And Acetaminophen launch?
Hydrocodone Bitartrate And Acetaminophen is a drug marketed by Mallinckrodt, Mikart, Chartwell, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Tris Pharma Inc, Vintage Pharms, Wes Pharma Inc, Abhai Llc, Able, Actavis Labs Fl Inc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Elite Labs Inc, Endo Operations, Epic Pharma Llc, Granules, Halsey, Ivax Pharms, Lannett Co Inc, Mutual Pharm, Novel Labs Inc, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sanaluz, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Ucb Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, and Watson Labs Florida. and is included in one hundred and twenty-six NDAs.
The generic ingredient in HYDROCODONE BITARTRATE AND ACETAMINOPHEN is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE AND ACETAMINOPHEN?
- What are the global sales for HYDROCODONE BITARTRATE AND ACETAMINOPHEN?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE AND ACETAMINOPHEN?
Summary for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
| US Patents: | 0 |
| Applicants: | 46 |
| NDAs: | 126 |
| Finished Product Suppliers / Packagers: | 41 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 8 |
| Patent Applications: | 386 |
| DailyMed Link: | HYDROCODONE BITARTRATE AND ACETAMINOPHEN at DailyMed |
Recent Clinical Trials for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sun Pharma Advanced Research Company Limited | Phase 1 |
| Grünenthal GmbH | Phase 1 |
| Teva Branded Pharmaceutical Products R&D, Inc. | Phase 3 |
See all HYDROCODONE BITARTRATE AND ACETAMINOPHEN clinical trials
Pharmacology for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
| Drug Class | Opioid Agonist |
| Mechanism of Action | Opioid Agonists |
US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040307-001 | Jul 26, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 203863-002 | Mar 30, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Labs Fl Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 206470-002 | Jun 2, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
